StockWatch
·

Aspira Pathlab & Diagnostics Ltd Q4 FY26 Results

ASPIRAQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue6.5227.4%12.9%
Total Income6.6626.9%12.8%
Expenditure7.358.0%41.8%
PBT-0.6955.9%195.3%
Net Profit-0.6955.9%195.3%
OPM-5.11%18.53pp23.35pp
NPM-10.34%19.41pp22.58pp
EPS0.6755.9%4.3%
View full financials

Informational and educational content only. Not investment advice.